Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer Meeting Abstract


Authors: Tan, D.; Farago, A.; Kummar, S.; Moreno, V.; Patel, J.; Lassen, U.; Solomon, B.; Rosen, L.; Leyvraz, S.; Reeves, J.; Brega, N.; Dima, L.; Childs, B.; Drilon, A.
Abstract Title: Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer
Meeting Title: 2020 World Conference on Lung Cancer
Keywords: trk; larotrectinib; ntrk gene fusions
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 3 Suppl.
Meeting Dates: 2021 Jan 28-31
Meeting Location: Singapore
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-03-01
Start Page: S176
Language: English
ACCESSION: WOS:000631349600202
PROVIDER: wos
DOI: 10.1016/j.jtho.2021.01.253
Notes: Meeting Abstract: MA11.09 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon